Data / Drug companies / Medisca Inc.
Medisca Inc.: 306 products in the FDA NDC directory, labeler code 38779
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Medisca Inc. (labeler code 38779) lists 306 products in the FDA National Drug Code Directory. By type: 306 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 22, 2026.
The request: Watch Medisca Inc. (FDA labeler code 38779): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 38779
- Products in commercial distribution
- 306
- Packages
- 1,455
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 11, Schedule III 10, Schedule IV 8
- Started marketing in the last 12 months
- 23
- Earliest marketing start
- June 2, 2005
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 185 | 60.5% |
| Bulk ingredients for compounding | 121 | 39.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 306 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 304 | 99.3% |
| Liquid | 2 | 0.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Trilostane | 38779-3352 | Powder | Bulk ingredients | September 22, 2026 |
| Doxycycline | 38779-3055 | Powder | Bulk ingredients | September 3, 2026 |
| Testosterone | 38779-3399 | Powder | Bulk ingredients | August 6, 2026 |
| Sodium ascorbate | 38779-3393 | Powder | Bulk ingredients | June 16, 2026 |
| Bimatoprost | 38779-3394 | Powder | Bulk ingredients | June 15, 2026 |
| Vitamin d3 | 38779-3370 | Powder | Bulk ingredients | June 2, 2026 |
| Sermorelin acetate | 38779-3389 | Powder | Bulk ingredients | June 1, 2026 |
| Rifaximin | 38779-3387 | Powder | Bulk ingredients | May 27, 2026 |
| Levothyroxine sodium | 38779-3375 | Powder | Bulk ingredients | May 27, 2026 |
| Enclomiphene citrate | 38779-3362 | Powder | Bulk ingredients | May 27, 2026 |
| Dexpanthenol, (d-panthenol) | 38779-3340 | Powder | Bulk ingredients | May 27, 2026 |
| Latanoprost | 38779-3289 | Powder | Bulk ingredients | April 23, 2026 |
| Semaglutide | 38779-3373 | Powder | Bulk ingredients | April 10, 2026 |
| Tirzepatide | 38779-3372 | Powder | Bulk ingredients | April 10, 2026 |
| Ivermectin | 38779-3317 | Powder | Bulk ingredients for compounding | April 9, 2026 |
| Hydroxocobalamin, (vitamin b12a) | 38779-3360 | Powder | Bulk ingredients | April 8, 2026 |
| Glutathione (l), ep (reduced) | 38779-3345 | Powder | Bulk ingredients | April 8, 2026 |
| Ascorbic acid | 38779-3368 | Powder | Bulk ingredients | February 11, 2026 |
| Quinacrine hydrochloride | 38779-3363 | Powder | Bulk ingredients | February 11, 2026 |
| Melatonin | 38779-3356 | Powder | Bulk ingredients | December 11, 2025 |
| Cromolyn sodium | 38779-3319 | Powder | Bulk ingredients | December 2, 2025 |
| Nad (nicotinamide adenine dinucleotide, oxidized) | 38779-3351 | Powder | Bulk ingredients | November 27, 2025 |
| Methylcobalamin | 38779-3350 | Powder | Bulk ingredients | November 14, 2025 |
| Alpha lipoic acid | 38779-3337 | Powder | Bulk ingredients | October 31, 2025 |
| Bezocaine | 38779-3334 | Powder | Bulk ingredients | September 2, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.